Pentylenetetrazol
Clinical data | |
---|---|
Trade names | Metrazol, others |
ATC code | |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Pentylenetetrazol, also known as pentylenetetrazole, leptazol, metrazol, pentetrazol (
Mechanism
The mechanism of pentylenetetrazol is not well understood, and it may have multiple
Several studies have focused on the way pentylenetetrazol influences neuronal ion channels. A 1987 study found that pentylenetetrazol increases calcium influx and sodium influx, both of which depolarize the neuron. Because these effects were antagonized by calcium channel blockers, pentylenetetrazol apparently acts at calcium channels, and it causes them to lose selectivity and conduct sodium ions, as well.[5]
Research
Pentylenetetrazol has been used experimentally to study seizure phenomena and to identify pharmaceuticals that may control seizure susceptibility. For instance, researchers can induce
See also
- List of investigational sleep drugs
- GABAA receptor negative allosteric modulator
- GABAA receptor § Ligands
References
- .
- ^ Minkel JR (February 25, 2007). "Drug May Counteract Down Syndrome". Scientific American. Retrieved 2007-03-20.
- ^ "Cardiazol-Paracodina". Agenzia Italiana del Farmaco.
- PMID 6090836.
- PMID 3503442.
- S2CID 26055062.